TrialJournal of cardiothoracic surgery2025
Rivaroxaban versus low molecular weight heparin for managing lower extremity deep vein thrombosis following thoracoscopic lung cancer surgery: a randomized controlled trial.
Lidan Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.